Cyclic Nucleotides and Blood Vessel Contraction
George L. Kramer, Joel G. Hardman
Abstract
George L. Kramer, Joel G. Hardman
Abstract
The sections in this article are: 1 Effects of Vasoactive Agents on Cyclic Nucleotide Levels 2 Effects of Externally Applied Cyclic Nucleotides 3 Adenylate and Guanylate Cyclases 4 Cyclic Nucleotide Phosphodiesterases and Phosphodiesterase Inhibitors 4.1 Distribution 4.2 Multiple Forms of Phosphodiesterase 4.3 Inhibitors 4.4 Comparative Studies in Hypertensive Rats 5 Cyclic Nucleotide-Dependent Protein Kinases 6 Interactions Between Cyclic Nucleotides and Ca2+ 7 conclusion7 Conclusion
OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The sections in this article are: 1 Effects of Vasoactive Agents on Cyclic Nucleotide Levels 2 Effects of Externally Applied Cyclic Nucleotides 3 Adenylate and Guanylate Cyclases 4 Cyclic Nucleotide Phosphodiesterases and Phosphodiesterase Inhibitors 4.1 Distribution 4.2 Multiple Forms of Phosphodiesterase 4.3 Inhibitors 4.4 Comparative Studies in Hypertensive Rats 5 Cyclic Nucleotide-Dependent Protein Kinases 6 Interactions Between Cyclic Nucleotides and Ca2+ 7 conclusion7 Conclusion
Key concepts: Nucleotide, Phosphodiesterase, Cyclic nucleotide phosphodiesterase, Cyclic nucleotide, Adenylate kinase, Cyclic gmp, Chemistry, Biochemistry